(Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv.
The agency said the patients died 3 to 4 days after receiving an appropriate dose of the medicine.
(Reporting by Ransdell Pierson; Editing by Gerald E. McCormick)
(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp